查詢結果分析
來源資料
相關文獻
- Osteocalcin in Patients with Rheumatoid Arthritis in One-Year Followup Study-Effect of Functional Stages, Inflammatory Activity and Therapy
- 類風濕性關節炎
- 類風濕性關節炎之最新治療趨勢
- 類風濕性關節炎與藥物治療
- 物理治療與類風濕性關節炎患者之手部
- Localized Chrysiasis Induced by Laser in a Patient with Rheumatoid Arthritis
- 雷射耳穴治療脊髓損傷患者疼痛的立即效果
- 臺灣大學物理治療畢業生現況之研究
- 肺臟和心肺移植及其物理治療
- 類風濕性關節炎的復健治療
頁籤選單縮合
題 名 | Osteocalcin in Patients with Rheumatoid Arthritis in One-Year Followup Study-Effect of Functional Stages, Inflammatory Activity and Therapy=類風濕性關節炎患者血清骨鈣素測定一年追蹤研究--功能等級, 發炎活動度, 和治療之影響 |
---|---|
作 者 | 黃春明; 周昌德; 林彩秀; 王秀娟; | 書刊名 | 中臺灣醫學科學雜誌 |
卷 期 | 3:2 1998.06[民87.06] |
頁 次 | 頁82-87 |
分類號 | 415.695 |
關鍵詞 | 類風濕性關節炎; 骨鈣素; 發炎活動力; 功能上等級; 治療; Rheumatoid arthritis; Osteocalcin; Inflammatory activity; Functional stages; Treatment; |
語 文 | 英文(English) |
中文摘要 | 類風濕性關節炎患者易造成骨質疏鬆是我們所熟知,但造成骨質流失之原因和機轉仍不十分清楚。骨鈣素是骨頭代謝之指標並可反應骨頭生成。我們用前瞻性方法以一年時間,探討類風濕性關節炎患者血清骨鈣素濃度是否因發炎活動度,功能等級和DMARD藥物治療之改變而變化。共有28位類風濕性關節炎患者納入本研究。經過一年治療,我們發現血清骨鈣素濃度有統計上之增加(1.48±0.96→2.18±1.88ng/mL,p<0.05)。然而,在發炎指數ESR(≧39mm/h)或CRP(≧3.9mg/dL)上升一個標準值之病人,其血清骨鈣素濃度並沒有統計上之改變。同樣地,在發炎指數ESR或CRP下降一個標準值之病人,其血清骨鈣素濃度也沒有統計上之增加。另外,我們發現ESR和CRP之變化和血清骨鈣素濃度之變化沒有相關性。我們資料顯示血清骨鈣素濃度在一年DMLARD治療後有明顯統計上之增加,可作為骨頭轉化之有效指數,但是,血清骨鈣素濃度似乎和功能上等級和發炎活動力沒有相關聯。 |
英文摘要 | It is well known that patients with rheumatoid arthritis (RA) have osteopenia. The etiology and the mechanisms producing this bone loss are poorly understood. Osteocalcin (OC) is a marker for bone metabolism and reflects bone formation.We investigated in a one-year prospective study whether the serum OC concentrations in patients with RA was significantly changed with the variation of inflammatory activity, functional stages, or disease modifying antirheumatic drug (DMARD)treatments. Twenty-eight RA patients was enrolled in this prospective study. After a one-year treatment, we could demonstrate statistical increase In OC values (1.48±0.96→2.18±1.88ng/mL,p<0.05 ). However, no significant differences in serum OC concentrations in patients who showed a fall in erythrocyte sedimentation rate (ESR) (≧1SD:39mm/h)or C reactive protein (CRP)(≧1SD:3.9mg/dL)were observed. Likewise, OC values of patients without such changes of inflammatory activity (ESR or CRP<1SD) did not increase. We found no correlation of ESR differences and CRP differences with OC differences. Our data suggested that OC levels, a useful follow-up variable of bone turnover, increased significantly after one year of DMARD treatment. This seemed, however, not to be associated with functional stages and inflammatory activity in patients with RA. |
本系統中英文摘要資訊取自各篇刊載內容。